MAC Clinical Research

MAC Clinical Research is a prominent, privately-held UK-based CRO that distinguishes itself through its ownership of a large network of dedicated clinical trial sites, providing significant control over patient recruitment and study execution. Its service portfolio is comprehensive, spanning traditional clinical operations, biometrics, pharmacovigilance, and specialized offerings like GMP manufacturing, sleep labs, and psychedelic testing suites. The company has established itself as a key partner for pharmaceutical and biotech clients, with a strong track record in complex therapeutic areas, particularly central nervous system disorders, and is actively involved in cutting-edge research such as psychedelic therapeutics.

Integrated 'site-centric' platform featuring a network of owned Dedicated Research Sites (including Early Phase, Memory, Psychedelic suites), the MAC EnVision® digital patient engagement platform, in-house bioanalytical/clinical pathology labs, and GMP manufacturing services.

MAC competes in the global CRO market against large public players like IQVIA, ICON, and Parexel, as well as many niche and regional CROs. Its primary competitive differentiation is its ownership of a dedicated site network, which most large CROs do not possess, offering greater control and integration. This positions it uniquely against both traditional service CROs and standalone clinical trial sites.